Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D1WN
|
|||
| Former ID |
DNC001299
|
|||
| Drug Name |
SBTI
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tissue kallikrein (KLK1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Endocrine and other factor-regulated calcium reabsorption | |||
| Reactome | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | |||
| WikiPathways | Blood Clotting Cascade | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Expression and characterization of human tissue kallikrein variants. Protein Expr Purif. 1998 Apr;12(3):361-70. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.